(Q48701274)

14 February 2018

title

Intratumoral autologous mononuclear cells in the treatment of recurrent glioblastoma multiforme. A phase 1 (toxicity) study. (English)

1 reference

14 February 2018

1 reference

P Steinbok

1

1 reference

14 February 2018

J P Thomas

series ordinal

2

1 reference

14 February 2018

L Grossman

series ordinal

3

1 reference

14 February 2018

C L Dolman

series ordinal

4

1 reference

14 February 2018

publication date

1 January 1984

1 reference

14 February 2018

Journal of Neuro-Oncology

published in

1 reference

14 February 2018

volume

2

1 reference

14 February 2018

issue

2

1 reference

14 February 2018

page(s)

147-151

1 reference

14 February 2018

https://scigraph.springernature.com/pub.10.1007/bf00177901

exact match

0 references

cites work

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

1 reference

12 December 2020

Tumour-associated surface antigen(s) in human astrocytomas

1 reference

12 December 2020

Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases

1 reference

12 December 2020

[Frequency and significance of lymphoplasmocyte infiltration in human gliomas (author's transl)].

1 reference

12 December 2020

Immunobiology of primary intracranial tumours. II. Analysis of lymphocyte subpopulations in patients with primary brain tumours

1 reference

12 December 2020

IS THE BRAIN "AN IMMUNOLOGICALLY PRIVILEGED SITE"?I. STUDIES BASED ON INTRACEREBRAL TUMOR HOMOTRANSPLANTATION AND ISOTRANSPLANTATION TO SENSITIZED HOSTS.

1 reference

12 December 2020

Immunobiology of primary intracranial tumours. III. Demonstration of a qualitative lymphocyte abnormality in patients with primary brain tumours

1 reference

12 December 2020

In vitro demonstration of cell-mediated immunity to human brain tumors.

1 reference

12 December 2020

Immunobiology of primary intracranial tumors. Part 1: studies of the cellular and humoral general immune competence of brain-tumor patients

1 reference

12 December 2020

Cell-bound antiglial immunity in patients with malignant tumors of the brain.

1 reference

12 December 2020

Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g

1 reference

12 December 2020

Tumor-specific membrane antigens in established cell lines from gliomas.

1 reference

12 December 2020

Surface antigenic characteristics of human glial brain tumor cells

1 reference

12 December 2020

[Immunotherapy for malignant gliomas (author's transl)]

1 reference

12 December 2020

Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye.

1 reference

12 December 2020

Lymphocytic infiltration in gliomas: evidence of possible host resistance.

1 reference

12 December 2020

[Active immunotherapy of cerebral tumor. 20 cases]

1 reference

12 December 2020

Relationship of lymphocyte invasion and survival of brain tumor patients

1 reference

12 December 2020

Inhibition of cell-mediated immunity in patients with brain tumors

1 reference

12 December 2020

Immunobiology of primary intracranial tumors. Part 3: Microcytotoxicity assays of specific immune responses of brain tumor patients

1 reference

12 December 2020

Immunotherapy with autologous white cell infusions (“lymphocytes”) in the treatment of recurrent glioblastoma multiforme.A preliminary report

1 reference

12 December 2020

Lymphocytic infiltration in long-survival glioblastomas: Possible host's resistance

1 reference

12 December 2020

Immune responses in patients with gliomas.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00177901

1 reference

14 February 2018

PubMed ID

6090602

1 reference

14 February 2018